Dec 31, 2018

United Therapeutics Q4 2018 Earnings Report

Total Revenue
$381M
Previous year: $465M
-17.9%
EPS
$3.34
Previous year: $3.89
-14.1%
Gross Profit
$350M
Previous year: $412M
-15.1%
Cash and Equivalents
$669M
Previous year: $705M
-5.1%
Free Cash Flow
$66.6M
Previous year: -$114M
-158.6%
Total Assets
$3.4B
Previous year: $2.88B
+18.1%

United Therapeutics

United Therapeutics